NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Daxor Corporation (DXR) Stock Analysis

Daxor Corporation (DXR) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

DXR

$9.77

+$0.02 (+0.21%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare DXR with… →

DXR Key Statistics

As of Oct 21, 2026
Trading
Open
$9.60
Previous Close
$9.75
Day's Range
9.60–9.77
52-Week Range
8.56–14.76
Volume
11.18K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.35
Valuation
Market Cap
$57.04M
P/E Ratio
8.88
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1,818.86
EPS (ttm)Profit attributable to each share over the last twelve months.
1.10
Financials (FY)
Revenue (FY)
$10.30M+383.53%
Net Income (FY)
$9.17M+1,609.71%
Profit marginThe share of revenue left as profit after all costs and taxes.
19,861.41%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
5.84M
1-Year Return
−27.84%
Dividend and dates
Avg Volume
18.38K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, DXR closed at $9.77, −27.84% over 1 year.

Daxor Corporation (DXR) has a market capitalization of $57.04M.

In fiscal 2025, DXR reported revenue of $10.30M.

DXR Stock Return by Calendar Year

Daxor Corporation (DXR) 10-year return: what $10,000 became

1 year
$10,000 $7,216
−27.84%
5 years
$10,000 $8,882
−11.18%
10 years
$10,000 $12,236
+22.36%

If you had invested $10,000 in Daxor Corporation (DXR) 10 years ago, at the close on October 21, 2016, it would have been worth $12,236 at the close on October 21, 2026: +22.36% in total, +2.04% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−33.76%
2025+91.81%
2024−19.90%
2023+4.80%
2022−18.87%
2021−9.68%
2020+32.98%
2019+14.63%
2018+80.70%
2017−44.54%
2016 (partial year)+3.36%

As of October 21, 2026.

DXR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$10.30M$9.17M89.0%
2024$2.13M$536.33K25.2%
2023$1.28M$280.64K21.9%
2022$6.31M$5.18M82.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$10.30M——$9.17M89.0%
2024$2.13M——$536.33K25.2%
2023$1.28M——$280.64K21.9%
2022$6.31M——$5.18M82.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

DXR Dividend History

$0.03

Dividends per share, 2018 · 1 payments

YearDividends per sharePaymentsChange
2018$0.031—
2016$0.031—

Most recent payment: $0.03 per share, ex-dividend January 5, 2018. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

DXR Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricDXRMedical Instruments & Supplies medianvs median
P/E8.8831.190.3x the median
P/S ratio1,818.862.60700.2x the median
Profit margin19,861.41%1.62%19,859.8 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Daxor Corporation (DXR) carries a market capitalisation of $57.04M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry.

The most recent close on file for DXR is $9.77, dated October 21, 2026. That is +$0.02 (+0.21%) against the previous close. Over the past 52 weeks the price has ranged from $8.56 to $14.76. The latest close sits 14.14% above that 52-week low.

Financial Health

In fiscal 2025, Daxor Corporation reported revenue of $10.30M. Against the prior fiscal year total of $2.13M, that is a change of +383.53%. The same year closed with net income of $9.17M. That is +1,609.71% against the prior fiscal year. Profit margin runs at 19,861.41%. That is 19,859.8 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 1.1.

Across the 4 fiscal years on file, revenue moves from $6.31M in 2022 to $10.30M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 8.88. That is 0.3 times the Medical Instruments & Supplies median of 31.19. Measured against sales, the shares trade at 1,818.86 times revenue. On price-to-sales that is 700.2 times the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.35. Daily returns over the trailing 10 years annualize to a volatility of 79.28%. Over the trailing twelve months the total return is −27.84%. Across 10 years the annualized return works out at +2.04%.

Growth & Income

The latest dividend on file for DXR dates from 2018. Dividends are recorded for 2 calendar years; 2018 shows 1 payments totalling $0.03 a share.

2026 is still running; the total return is −33.76% year to date. Across the complete calendar years on file, 2025 returned +91.81% and 2017 returned −44.54%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

Daxor Corporation (DXR) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Daxor Corporation DXR $57.04M 8.9
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Daxor Corporation trades at a P/E of 8.9.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Daxor Corporation

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Visit website →